BioNTech SE
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.
5192 employees · est. 2008 · Mainz, Germany
BioNTech SE
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.
5202 employees · est. 2008 · Mainz, Germany
Side-by-Side Comparison
| Metric | BioNTech SE | BioNTech SE |
|---|---|---|
| Founded | ||
| Founded | 2008 | 2008 |
| Headquarters | ||
| Headquarters | Mainz, Germany | Mainz, Germany |
| Employees | ||
| Employees | 5192 | 5202 |
| Industry | ||
| Industry | Health Care | Biopharma, Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Not tracked yet | IPO |
| Total Funding | ||
| Total Funding | Not tracked yet | $1.49B |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 9 |
| Services | ||
| Services | Development of immunotherapies, mRNA vaccine development, Oncology treatment advancement, Research & Innovation | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients, Medical professionals, Healthcare institutions, Research collaborators | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunotherapy, MRNA Therapeutics, Oncology, Individualized Cancer Medicine, Patient-specific Immunotherapy, CAR T Cells, Bispecific Antibodies, Antibody-drug Conjugates, Small Molecule Immunomodulators, Infectious Diseases, Cell Therapy, Protein-based Therapeutics, Chimeric Antigen Receptor | MRNA Therapeutics, Immunotherapy, Oncology, Cell Therapy, Antibody Therapeutics, Rare Diseases, Infectious Diseases, Bispecific Antibodies, Individualized Cancer Medicine, Patient-specific Immunotherapy |
| Website | ||
| Website | biontech.de | biontech.com |
About BioNTech SE
BioNTech SE, founded in 2008 and headquartered in Germany, is a distinguished player in the Health Care industry, aiming to leverage the immune system for novel therapies against cancer and infectious diseases. With a workforce of approximately 6,100, BioNTech is notable for its extensive computatio...
About BioNTech SE
BioNTech SE, founded in 2008, is a Germany-based leader in Biopharma and Biotechnology industries. Upholding the vision to harness the immune system against cancer and infectious diseases, the company specializes in developing cutting-edge immunotherapies. Their impressive global presence, reflecte...
We will tell you when either one moves
BounceWatch watches BioNTech SE and BioNTech SE for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BioNTech SE and BioNTech SE — by email.
Frequently Asked Questions
Compare BioNTech SE with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at BioNTech SE on 19 Jun 2026, and BioNTech SE on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.